The diagnosis and treatment of hairy-cell leukaemia

Blood Reviews

Volumn 16, Issue 4, 2002, Pages 255-262

  Allsup, D J ^a   Cawley, J C ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Hairy cell leukaemia; Nucleoside treatment

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; B LYMPHOCYTE ANTIBODY; CD22 ANTIBODY; CD22 ANTIGEN; CLADRIBINE; COTRIMOXAZOLE; DEOXYADENOSINE DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; NUCLEOSIDE DERIVATIVE; PENTOSTATIN; PURINE DERIVATIVE; RITUXIMAB; UNCLASSIFIED DRUG; PURINE NUCLEOSIDE;

BLOOD EXAMINATION; BONE MARROW EXAMINATION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CYTOCHEMISTRY; FEBRILE NEUTROPENIA; HAIRY CELL LEUKEMIA; HUMAN; IMMUNOPHENOTYPING; INFECTION; LABORATORY DIAGNOSIS; PHOTOSENSITIVITY; PNEUMOCYSTOSIS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; METHODOLOGY; PATHOLOGY; REMISSION;

BONE MARROW EXAMINATION; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, HAIRY CELL; PURINE NUCLEOSIDES; REMISSION INDUCTION;

EID: 0036883686     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(02)00044-9     Document Type: Review

References (70)

1. Bouroncle BA. Thirty-five years in the progress of hairy cell leukemia. Leuk Lymphoma 1994; 14(suppl 1): 1-12.
2. Staines A, Cartwright RA. Hairy-cell leukaemia; descriptive epidemiology and a case control study. Br J Haematol 1993; 85: 714-717.
3. Bouroncle BA. Unusual presentations and complications of hairy-cell leukemia. Leuk Lymphoma 1987; 1: 288-293.
4. Mehta AB, Catovsky D, O'Brien CJ, Lott M, Bowley N, Hemmingway A. Massive retroperitoneal lymphadenopathy as a terminal event in hairy-cell leukemia. Clin Lab Haematol 1983; 5(3): 259-263.
5. Mercieca J, Puga M, Matutes E, Moskovic E, Salim S, Catovsky D. Incidence and significance of abdominal lymphadenopathy in hairy-cell leukemia. Leuk Lymphoma 1994; 14(suppl 1): 79-83.
6. Piro LD, Ellison DJ, Saven A. The Scripps Clinic experience with 2-chlorodeoxy-denosine in the treatment of hairy cell leukemia. Leuk Lymphoma 1994; 14(suppl 1): 121-125.
7. Marie JP, Degos L, Flandrin G. Hairy cell leukemia and tuberculosis. New Eng J Med 1977; 297: 1354.
8. Zuzel M, Cawley JC, Paton RC, Burns GF, McNichol GP. Platelet function in hairy-cell leukaemia. J Clin Pathol 1979; 32: 814-821.
9. Cawley JC, Burns GF, Hayhoe FGH, eds. Hairy-cell Leukaemia. Heidleberg: Springer; 1980.
10. Farcet JP, Weschler J, Wirquin V, Divine M, Reyes F. Vasculitis in hairy-cell leukemia. Arch Intern Med 1987; 147(4): 660-664.
11. Pope A, Lazarchick J, Hoyer L, Weinstein A. Hairy-cell leukemia and vasculitis. J Rheumatol 1980; 7(6): 895-899.
12. Westbrook CA, Golde DW. Autoimmune disease in hairy-cell leukaemia-clinical syndromes and treatment. Br J Haematol 1985; 61(2): 349-356.
13. Demeter J, Grotes HJ, Horvath C et al. Bone densitometry and histomorphometry in patients with hairy cell leukemia. Leuk Lymphoma 1994; 14(suppl 1): 73-77.
14. Lembesky BC, Ratain MJ, Golomb HM. Skeletal complications in hairy cell leukemia: Diagnosis and therapy. J Clin Oncol 1988; 6(8): 1280-1284.
15. VanderMolen LA, Urba WJ, Longo DL, Lawrence J, Gralnick H, Steis RG. Diffuse osteosclerosis in hairy cell leukemia. Blood 1989; 74(6): 2066-2069.
16. Herold CJ, Wittich GR, Schwarzinger I et al. Skeletal involvement in hairy cell leukaemia. Skeletal Radiol 1988; 17(3): 171-175.
17. Jansen J, Bolhuis RLH, Vanieuwkoop JA, Schuit HRE, Kroese WFS. Paraproteinemia plus osteolytic lesions in typical hairy-cell leukaemia. Br J Haematol 1983; 54(4): 531-541.
18. Bentz M, Dohner H, Guckel F et al. Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy-cell leukemia treated with pentostatin or α-interferon. Leukemia 1991; 5(10): 905-907.
19. Catovsky D. Hairy cell leukaemia and prolymphocytic leukaemia. Clin Haematol 1997; 6: 245-268.
20. Lewis SM, Catovsky D, Hows JM, Ardalan B. Splenic red cell pooling in hairy cell leukaemia. Br J Haematol 1977; 35: 351-357.
21. Spriggs Al. Hairy cells. Lancet 1976; i: 427.
22. Katayama I, Li CY, Yam LT. Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis. Cancer 1972; 29: 157-164.
23. Janckila AJ, Latham MD, Lam KW, Chow KC, Li CY, Yam LT. Heterogeneity of hairy cell tartrate-resistant acid phosphatase. Clin Biochem 1992; 25(6): 437-443.
24. Drexler HG, Gignac SM. Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in hematopoietic cells. Leukemia 1994; 8(3): 359-368.
25. Matutes E, Morilla R, Owusu-Ankomatz K, Houlihan A, Meeus P, Catovsky D. The immunophenotype of hairy cell leukaemia (HCL). Proposals for a scoring system to distinguish HCL from B-cell disorders with hairy or villars lymphocytes. Leuk Lymphoma 1994; 14(suppl 1): 57-61.
26. Hansen DA, Robbins BA, Bylund DJ, Piro LD, Saven A, Ellison DJ. Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia. Am J Clin Pathol 1994; 102(5): 580-585.
27. Burke JS. The value of the bone marrow in the diagnosis of hairy-cell leukemia. Am J Clin Pathol 1978; 70(6): 876-884.
28. Lisse I, Hasselbalch H, Junker P. Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. Apmis 1991; 99: 171-178.
29. Robbins BA, Ellison DJ, Spinosa JC et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993; 82(4): 1277-1287.
30. Janckila AJ, Cardwell EM, Yam LT, Li CY. Hairy cell identification by immunocytochemistry of tartrate resistant acid phosphatase. Blood 1995;85:2839-2844.
31. Ellison DJ, Sharpe RW, Robbins BA et al. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 1994; 84(12): 4310-4315.
32. Burke JS, Byrne GE, Rappaport H. Hairy cell leukemia (leukemic reticuloendotheliosis). A clinical pathologic study of 21 patients. Cancer 1974; 33: 1399-1410.
33. Nanba K, Jaffe ES, Soban EJ, Braylan RC, Berard CW. Hairy cell leukemia. Enzyme histochemical characterisation, with special reference to splenic stromal changes. Cancer 1977; 39: 2323-2336.
34. Nanba K, Soban EJ, Bowling MC, Berard CW. Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive features of hairy cell leukemia. Am J Clin Pathol 1977; 67: 415-426.
35. Haglund U, Juliusson G, Stellan B, Gahrton G. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood 1994; 83(9): 2637-2645.
36. Han T, Sadamori N, Block AM et al. Cytogenetic studies in chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia: A progress report. Nouv Rev Fr Hematol 1988; 30(5/6): 393-395.
37. Juliusson G, Gahrton G. Cytogenetics in CLL and related disorders. In: Rozman C, ed. Bailliere's Clinical Haematology, vol. 6:4. London: Bailliere Tindall; 1993: 821-848.
38. Miller ML, Fishleder AJ, Tubbs RR. The expression of CD22 (Leu 14) and CD IIc (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. Am J Clin Pathol 1991; 96(1): 100-108.
39. Saven A, Burian C, Koziol JA, Piro LD. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918-1926.
40. Cheson BD, Sorenson M, Vena DA et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: A report of 979 patients. J Clin Oncol 1998; 16(9): 3007-3015.
41. Nafel M, Cervantes F, Beltran JM et al. Deoxycoformycin in the treatment of patients with hairy cell leukemia. Cancer 2000; 88: 352-357.
42. Ribeiro P, Bouaffia F, Peaud PY et al. Long-term outcome of patients with hairy cell leukemia treated with pentostatin. Cancer 1999; 85: 65-71.
43. Flinn IW, Kopaky KJ, Foucar MK et al. Long-term follow-up of remission duration, mortality and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 2000; 96: 2981-2986.
44. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Eng J Med 1990; 322: 1117-1121.
45. Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduced infectious complications. Haematologica 1999; 84: 22-25.
46. Chackoo J, Murphy C, Duggan C, O'Brian S, Broune PV, McCann SR. Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia. Br J Haematol 1999; 105: 1145-1146.
47. Urba WJ, Baseler MW, Kopp WC et al. Deoxycoformycin-induced immuno-suppression in patients with hairy cell leukemia. Blood 1989; 73: 38-46.
48. Catovsky D, Matutes E, Talavera JG et al. Long-term results with 2′-deoxy-coformycin in hairy cell leukemia. Leuk Lymphoma 1994; 14(suppl 1): 109-113.
49. Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine. Br J Haematol 1999; 106: 515-519.
50. BCSH Blood Transfusion Task Force. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfus. Med. 1996; 6: 261-271.
51. Matutes E, Meeus P, McLennan K, Catovsky D. The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin; a long-term follow-up study. Br J Haematol 1997; 98: 375-383.
52. Habermann TM, Andersen JW, Cassileth PA, Bennett JM, Oken MM. Sequential administration of recombinant interferon α and deoxycoformycin in the treatment of hairy cell leukaemia. Br J Haematol 1992; 80: 466-471.
53. Ambersley J, Golde DW. Therapy for neutropenia in hairy cell leukemia with recombinant granulocyte colony-stimulating factor. Ann Int Med 1988; 109: 789-795.
54. Lorber C, Willfort A, Ohler L et al. Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon α therapy of neutropenic patients with hairy cell leukaemia. Ann Hematol 1993; 67: 13-16.
55. Catovsky D. British Committee for Standards in Haematology. Guidelines on diagnosis and therapy. Hairy Cell Leukaemia. Darwin Medical Communication Ltd. 2000.
56. Kraut EH, Grever MR, Bouroncle BA. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood 1994; 84: 4061-4063.
57. Mercieca J, Matutes E, Moskovic E et al. Massive abdominal lymphadenopathy. Br J Haematol 1992; 82: 547-554.
58. Hagberg H, Lundholm L. Rituximab, a chimaeric anti-CD20 monoclonal antibody in the treatment of hairy cell leukaemia. Br J Haematol 2001; 115: 609-611.
59. Lauria F, Lenoci M, Annino L et al. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukaemia. Haematologica 2001; 86: 1046-1050.
60. Kreitman RJ, Wilson WH, Bergeron K et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Eng J Med 2001; 345(4): 241-247.
61. Tulliez M, Henry-Amar M, Bryon PA, Flandrin G. Splenic lymphoma with villous lymphocytes: Clinical presentation, biology, and prognostic factors in a series of 100 patients. Br J Haematol 1996; 93: 731-736.
62. Lefrere F, Hermine O, Belanger C et al. Fludarabine: An effective treatment in patients with splenic lymphoma with villous lymphocytes. Leukemia 2000; 14(4): 573-575.
63. Sainati L, Matutes E, Mulligan S et al. A variant form of hairy cell leukemia resistant to α-interferon: Clinical and phenotypic characteristics of 17 patients. Blood 1990; s76: 157-162.
64. Blasinska-Morawiec M, Robak T, Krykowski E, Hellman A, Urbanska-Rys H. Hairy cell leukemia-variant treated with 2′-chlorodeoxyadenosine: A report of three cases. Leuk Lymphoma 1997; 25: 381-385.
65. Tetreault SA, Robbins BA, Saven A. Treatment of hairy cell leukemia-variant with cladribine. Leuk Lymphoma 1999; 35(3-4): 347-354.
66. Han T, Sadamori N, Block AM et al. Cytogenetic studies in chronic lymphocytic Leukemia, prolymphocytic leukemia, and hairy cell leukemia: A progress report. Nouv Rev Fr Hematol 1988; 30(5/6): 393.
67. Juliusson G, Gahrton G. Cytogenetics in CLL and related disorders. In: Rozman C, ed. Bailliere's Clinical Haematology, vol. 6:4. London: Balliere Tindall; 1993: 821.
68. Haglund U, Juliusson G, Stellan B et al. Hairy cell leukemia is characterised by Clonal chromosome abnormalities clustered to specific regions. Blood 1994; 83(9): 2637-2645.
69. Valtranatou K, Brito-Babapulle V, Matutes E et al. p53 Gene deletion and trisomy 12, in hairy-cell leukaemia and its variant. Leuk Res 1999; 23: 1041-1045.
70. Ellison DJ, Sharpe RW, Robbins BA et al. Immunomorphologic analysis of bone Marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukaemia. Blood 1994; 84: 4310-4315.